About NuProbe
NuProbe is a company based in George Town (Cayman Islands) founded in 2016 by Junfeng Luo, Yundi Chen, Yingshuang Chai, Victor Shi, Peng Yin, and David Yu Zhang.. NuProbe has raised $61 million across 4 funding rounds from investors including Astrazeneca, CICC and WuXi AppTec. NuProbe offers products and services including BDA Technology, QASeq, and Custom Assay Development. NuProbe operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter George Town, Cayman Islands
- Founders Junfeng Luo, Yundi Chen, Yingshuang Chai, Victor Shi, Peng Yin, David Yu Zhang
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$61 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series B
Jan 11, 2021
-
Investors
Astrazeneca
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NuProbe
NuProbe offers a comprehensive portfolio of products and services, including BDA Technology, QASeq, and Custom Assay Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables selective PCR amplification of low-abundant DNA variants.
Detects mutations and copy variations using multiplexed PCR.
Provides tailored assays for biomarker detection in research.
Unlock access to complete
Unlock access to complete
Funding Insights of NuProbe
NuProbe has successfully raised a total of $61M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $50.0M
-
First Round
First Round
(23 Apr 2018)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series B - NuProbe | Valuation | BioTrack Capital , Yonghua Capital | |
| Sep, 2019 | Amount | Grant - NuProbe | Valuation |
investors |
|
| Sep, 2018 | Amount | Grant - NuProbe | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NuProbe
NuProbe has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Astrazeneca, CICC and WuXi AppTec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NuProbe
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NuProbe
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nuprobe Comparisons
Competitors of NuProbe
NuProbe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nuprobe
Frequently Asked Questions about NuProbe
When was NuProbe founded?
NuProbe was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is NuProbe located?
NuProbe is headquartered in George Town, Cayman Islands.
Is NuProbe a funded company?
NuProbe is a funded company, having raised a total of $61M across 4 funding rounds to date. The company's 1st funding round was a Grant of $1.69M, raised on Apr 23, 2018.
What does NuProbe do?
NuProbe was founded in 2016 in George Town, Cayman Islands, within the biotechnology sector. A multiplexed platform for quantitative PCR is provided, featuring toehold probe designs that enable discrimination of single nucleotide variants through thermodynamics-guided methods. Applications are targeted at rare allele detection in cancer diagnostics, noninvasive prenatal testing, infectious disease screening, and related fields. Operations focus on tool development for these diagnostic areas.
Who are the top competitors of NuProbe?
NuProbe's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does NuProbe offer?
NuProbe offers BDA Technology, QASeq, and Custom Assay Development.
Who are NuProbe's investors?
NuProbe has 14 investors. Key investors include Astrazeneca, CICC, WuXi AppTec, HHS, and BioTrack Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.